153
Views
14
CrossRef citations to date
0
Altmetric
Article

Interleukin‐1β and interleukin‐1 receptor antagonist gene polymorphisms in Korean patients with adult‐onset Still's disease

, , , &
Pages 390-393 | Accepted 13 Mar 2007, Published online: 12 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Yuya Fujita, Hiroshi Furukawa, Tomoyuki Asano, Shuzo Sato, Makiko Yashiro Furuya, Hiroko Kobayashi, Hiroshi Watanabe, Eiji Suzuki, Tomohiro Koga, Toshimasa Shimizu, Yukitaka Ueki, Katsumi Eguchi, Naoyuki Tsuchiya, Atsushi Kawakami & Kiyoshi Migita. (2019) HLA-DQB1 DPB1 alleles in Japanese patients with adult-onset Still’s disease. Modern Rheumatology 29:5, pages 843-847.
Read now
MY Jung, SW Kang, SK Kim, H-J Kim, DH Yun, S-V Yim, SJ Hong & J-H Chung. (2010) The interleukin-1 family gene polymorphisms in Korean patients with rheumatoid arthritis. Scandinavian Journal of Rheumatology 39:3, pages 190-196.
Read now
Katarzyna Lacka, Agnieszka Paradowska, Teresa Gasinska, Joanna Soszynska, Hanna Wichary, Lucyna Kramer & Jan K. Lacki. (2009) Interleukin-1β Gene (IL-1β) Polymorphisms (SNP –511 and SNP +3953) in Thyroid-Associated Ophthalmopathy (TAO) among the Polish Population. Current Eye Research 34:3, pages 215-220.
Read now

Articles from other publishers (11)

Kawaljit Kaur, Po-Chun Chen, Meng-Wei Ko & Anahid Jewett. (2022) The Role of Checkpoint Inhibitors in Autoimmune Diseases: Similarities and Differences Compared with Cancer. Critical Reviews in Immunology 42:3, pages 23-36.
Crossref
Piero Ruscitti, Onorina Berardicurti, Roberto Giacomelli & Paola Cipriani. (2021) The clinical heterogeneity of adult onset Still’s disease may underlie different pathogenic mechanisms. Implications for a personalised therapeutic management of these patients. Seminars in Immunology 58, pages 101632.
Crossref
Ju-Yang Jung, Ji-Won Kim, Chang-Hee Suh & Hyoun-Ah Kim. (2020) Roles of Interactions Between Toll-Like Receptors and Their Endogenous Ligands in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still’s Disease. Frontiers in Immunology 11.
Crossref
Roberto Giacomelli, Piero Ruscitti & Yehuda Shoenfeld. (2018) A comprehensive review on adult onset Still's disease. Journal of Autoimmunity 93, pages 24-36.
Crossref
Tejasvi H.T. (2018) ADULT ONSET STILL’S DISEASE-A DIAGNOSIS OF EXCLUSION. Journal of Evidence Based Medicine and Healthcare 5:15, pages 1348-1350.
Crossref
Mathieu Gerfaud-Valentin, Yvan Jamilloux, Jean Iwaz & Pascal Sève. (2014) Adult-onset Still's disease. Autoimmunity Reviews 13:7, pages 708-722.
Crossref
C. M. Hedrich, N. Bruck, B. Fiebig & M. Gahr. (2011) Anakinra: A safe and effective first-line treatment in systemic onset juvenile idiopathic arthritis (SoJIA). Rheumatology International 32:11, pages 3525-3530.
Crossref
Clio P. Mavragani, Evangelos G. Spyridakis & Michael Koutsilieris. (2012) Adult-Onset Still’s Disease: From Pathophysiology to Targeted Therapies. International Journal of Inflammation 2012, pages 1-10.
Crossref
Cecilia Giampietro & Bruno Fautrel. (2012) Anti-Interleukin-1 Agents in Adult Onset Still's Disease. International Journal of Inflammation 2012, pages 1-6.
Crossref
I. Kötter & G. Horneff. (2010) IL-1-AntagonistenIL-1 antagonists. Zeitschrift für Rheumatologie 69:7, pages 581-593.
Crossref
P. Lamprecht. (2009) Adulter Morbus Still, Schnitzler-Syndrom und autoinflammatorische Syndrome im ErwachsenenalterAdult-onset Still’s disease, Schnitzler syndrome, and autoinflammatory syndromes in adulthood. Zeitschrift für Rheumatologie 68:9, pages 740-746.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.